CVS Health Corp (CVS) support and resistance · P/E 16, rev $402.07B
CVS Health Corp (CVS) is a healthcare plans company listed on US.
This page maps CVS Health Corp (CVS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CVS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CVS quote page for the session range and the stock page for the full model.
Not investment advice.